Medical Research
(H03)
990 on File
INTERNATIONAL SOCIETY OF AMYLIODOSIS
Financial strength (30%)
92/100
Reliability (20%)
40/100
Effectiveness (25%)
68/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$2.3M
Total Revenue
$641K
Total Expenses
$2.3M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
74.1%
Fundraising Efficiency
N/A
Operating Reserve
43.80x
Liability-to-Asset
6.0%
Revenue Diversification
74.4%
Compared with Peers
FY 2024
Compared with 726 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
74.1% | 84.5% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
25.9% | 11.4% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
43.8 mo | 13.4 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
6.0% | 0.4% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
74.4% | 93.3% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
230.1% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
113.3% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
72.1% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $2.3M | $641K | $2.3M | 74.1% | 0 |
| 2023 | $697K | $301K | $681K | 99.6% | 0 |
| 2022 | $131K | $132K | $284K | 97.5% | — |
| 2021 | $249K | $89K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.